Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05954299 · ClinicalTrials.gov registry record
Vincere Biobank Research Protocol
A clinical trial of Cancer, sponsored by Vincere Cancer Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05954299 is a study of Cancer that is actively recruiting participants, run by Vincere Cancer Center. The registered enrollment target is 5,000 participants, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05954299, a study of Cancer, is actively recruiting participants, sponsored by Vincere Cancer Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.
Conditions Studied
Study Locations (1)
Arizona
- Vincere Cancer Center - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-07-18 |
| Est. Completion | 2038-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05954299
The ClinicalTrials.gov registry entry for NCT05954299 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher). The listed sponsor is Vincere Cancer Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05954299 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05954299 about?
NCT05954299 is a clinical study titled "Vincere Biobank Research Protocol". The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.
What is the current status of trial NCT05954299?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-07-18. Estimated completion is 2038-12-31.
What conditions does trial NCT05954299 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT05954299?
This trial is sponsored by Vincere Cancer Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05954299 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.